Цей переклад готується. Тимчасово ми показуємо оригінальну версію англійською мовою.
Бізнес · 12.07.20191 хв читання
Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Public Workshop; Cancellation
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration is announcing the cancellation of a public workshop entitled "Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients" that was previously scheduled for August 8, 2019, from 8:30 a.m. to 4:30 p.m. This public workshop was announced in the Federal Register of May 2, 2019. The meeting has been cancelled due to unforeseen changes in the adenovirus drug development landscape.
Оригінальна мова джерела: Federal Register — Food and Drug AdministrationВідкрити оригінальне повідомлення →